BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31834604)

  • 1. Thirteen novel CLCNKB variants and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3.
    Han Y; Cheng H; Shao S; Lang Y; Zhao X; Lin Y; Wang S; Shi X; Liu Z; Shao L
    Endocrine; 2020 Apr; 68(1):192-202. PubMed ID: 31834604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CLCNKB variant in a Chinese family with classic Bartter syndrome and prenatal genetic diagnosis.
    Zhao Q; Xiang Q; Tan Y; Xiao X; Xie H; Wang H; Yang M; Liu S
    Mol Genet Genomic Med; 2022 Oct; 10(10):e2027. PubMed ID: 35913199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing Characterization of
    Wang C; Han Y; Zhou J; Zheng B; Zhou W; Bao H; Jia Z; Zhang A; Huang S; Ding G; Zhao F
    Front Genet; 2020; 11():81. PubMed ID: 32153641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome.
    García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Madrid Á; Chocrón S; Nadal I; Navarro M; Lucas E; Fijo J; Espino M; Espitaletta Z; García Nieto V; Barajas de Frutos D; Loza R; Pintos G; Castaño L; ; Ariceta G
    PLoS One; 2017; 12(3):e0173581. PubMed ID: 28288174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions.
    Tschernoster N; Erger F; Kohl S; Reusch B; Wenzel A; Walsh S; Thiele H; Becker C; Franitza M; Bartram MP; Kömhoff M; Schumacher L; Kukat C; Borodina T; Quedenau C; Nürnberg P; Rinschen MM; Driller JH; Pedersen BP; Schlingmann KP; Hüttel B; Bockenhauer D; Beck B; Altmüller J
    Genome Med; 2023 Aug; 15(1):62. PubMed ID: 37612755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report.
    Zhu B; Jiang H; Cao M; Zhao X; Jiang H
    BMC Med Genet; 2019 Aug; 20(1):137. PubMed ID: 31409296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress of research on the role of CLCNKB gene in classical Bartter syndrome].
    Zhou J; Wang C; Bao H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 May; 37(5):573-577. PubMed ID: 32335890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.
    Brochard K; Boyer O; Blanchard A; Loirat C; Niaudet P; Macher MA; Deschenes G; Bensman A; Decramer S; Cochat P; Morin D; Broux F; Caillez M; Guyot C; Novo R; Jeunemaître X; Vargas-Poussou R
    Nephrol Dial Transplant; 2009 May; 24(5):1455-64. PubMed ID: 19096086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A founder mutation in the CLCNKB gene causes Bartter syndrome type III in Spain.
    Rodríguez-Soriano J; Vallo A; Pérez de Nanclares G; Bilbao JR; Castaño L
    Pediatr Nephrol; 2005 Jul; 20(7):891-6. PubMed ID: 15875219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome.
    Lee JW; Lee J; Heo NJ; Cheong HI; Han JS
    J Korean Med Sci; 2016 Jan; 31(1):47-54. PubMed ID: 26770037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation spectrum of Chinese patients with Bartter syndrome.
    Han Y; Lin Y; Sun Q; Wang S; Gao Y; Shao L
    Oncotarget; 2017 Nov; 8(60):101614-101622. PubMed ID: 29254190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation associated with Type III Bartter syndrome: A report of five cases.
    Li Y; Wu C; Gu J; Li D; Yang Y
    Mol Med Rep; 2019 Jul; 20(1):65-72. PubMed ID: 31115572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of Bartter syndrome in Korea.
    Lee BH; Cho HY; Lee H; Han KH; Kang HG; Ha IS; Lee JH; Park YS; Shin JI; Lee DY; Kim SY; Choi Y; Cheong HI
    Nephrol Dial Transplant; 2012 Apr; 27(4):1516-21. PubMed ID: 21865213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel compound heterozygous CLCNKB gene mutations (c.1755A>G/c.848_850delTCT) cause classic Bartter syndrome.
    Wang C; Chen Y; Zheng B; Zhu M; Fan J; Wang J; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F844-F851. PubMed ID: 29442545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Genotype-Phenotype Correlation of
    Yun Y; Park SS; Lee S; Seok H; Park S; Lee SY
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the CLCNKB gene in Japanese patients with classic Bartter syndrome.
    Tajima T; Nawate M; Takahashi Y; Mizoguchi Y; Sugihara S; Yoshimoto M; Murakami M; Adachi M; Tachibana K; Mochizuki H; Fujieda K
    Endocr J; 2006 Oct; 53(5):647-52. PubMed ID: 16902263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.
    Konrad M; Vollmer M; Lemmink HH; VAN DEN Heuvel LPWJ; Jeck N; Vargas-Poussou R; Lakings A; Ruf R; Deschênes G; Antignac C; Guay-Woodford L; Knoers NVAM; Seyberth HW; Feldmann D; Hildebrandt F
    J Am Soc Nephrol; 2000 Aug; 11(8):1449-1459. PubMed ID: 10906158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight novel KCNJ1 variants and parathyroid hormone overaction or resistance in 5 probands with Bartter syndrome type 2.
    Zuo J; Guo W; Wang S; Lang Y; Wang S; Shi X; Zhang R; Zhao X; Han Y; Shao L
    Clin Chim Acta; 2020 Dec; 511():248-254. PubMed ID: 33058840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bartter syndrome type III with only a synonymous mutation of the
    Xue Y; Wang B; Tang R; Ni H; Chen P; Liu BC; Zhang X
    Clin Nephrol; 2019 Dec; 92(6):325-328. PubMed ID: 31661060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Genetic Spectrum of Bartter Syndrome Type 3.
    Seys E; Andrini O; Keck M; Mansour-Hendili L; Courand PY; Simian C; Deschenes G; Kwon T; Bertholet-Thomas A; Bobrie G; Borde JS; Bourdat-Michel G; Decramer S; Cailliez M; Krug P; Cozette P; Delbet JD; Dubourg L; Chaveau D; Fila M; Jourde-Chiche N; Knebelmann B; Lavocat MP; Lemoine S; Djeddi D; Llanas B; Louillet F; Merieau E; Mileva M; Mota-Vieira L; Mousson C; Nobili F; Novo R; Roussey-Kesler G; Vrillon I; Walsh SB; Teulon J; Blanchard A; Vargas-Poussou R
    J Am Soc Nephrol; 2017 Aug; 28(8):2540-2552. PubMed ID: 28381550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.